Literature DB >> 1977515

Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

T Sato1, A Tanigami, K Yamakawa, F Akiyama, F Kasumi, G Sakamoto, Y Nakamura.   

Abstract

Allele loss on a specific chromosome has implied the existence of a tumor suppressor gene such as the p53 gene and the RB gene. In order to determine which chromosome(s) carries a tumor suppressor gene(s) that contributes to tumor progression in primary breast cancer, we analyzed the loss of heterozygosity for each autosomal chromosome arm by using 39 restriction fragment length polymorphism markers including 25 variable numbers of tandem repeat probes. In 79 primary breast cancers, we found the frequent loss on the long arm of chromosome 13 (21%), the long arm of chromosome 16 (45%), and the short arm of chromosome 17 (56%). Interestingly, breast cancers in which loss of both chromosomes 13q and 17p was detected showed more malignant histopathological features, and a group of the tumors in which chromosome 16q loss was detected presented with frequent lymph node metastasis. Furthermore, the result of the deletion mapping on chromosome 17p implied the existence of a tumor suppressor gene distal to the p53 gene as well as the p53 gene itself for primary breast cancer. These results suggest that at least 4 tumor suppressor genes exist on chromosomes 13q, 16q, and 17p for primary breast cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977515

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  123 in total

1.  Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.

Authors:  X Cui; H Feiner; Z Lin; H Li
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

3.  Low Grade Amplification of MDM2 Gene in a Subset of Human Breast Cancers without p53 Alterations.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

4.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Cadherins, steroids and cancer.

Authors:  O W Blaschuk; S B Munro; R Farookhi
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

6.  Loss of heterozygosity in lobular carcinoma in situ of the breast.

Authors:  S R Lakhani; N Collins; J P Sloane; M R Stratton
Journal:  Clin Mol Pathol       Date:  1995-04

Review 7.  Analysis of genetic linkage and somatic loss of heterozygosity in affected pairs of first-degree relatives.

Authors:  K Rohde; M D Teare; M Santibáñez Koref
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

8.  E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study.

Authors:  S Dorudi; J P Sheffield; R Poulsom; J M Northover; I R Hart
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 9.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

10.  Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.

Authors:  M Schutte; L T da Costa; S A Hahn; C Moskaluk; A T Hoque; E Rozenblum; C L Weinstein; M Bittner; P S Meltzer; J M Trent
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.